Sign In

Rebecca Holmberg

Associate Director, Global Portfolio & Project Management at AstraZeneca

Rebecca Holmberg is a seasoned professional with a strong background in molecular diagnostics product development.

Having extensive experience in leading multidisciplinary teams, Rebecca has actively contributed to the creation of applications for infectious and genetic diseases like encephalitis, Mycobacterium tuberculosis, and influenza.

Currently serving as the Associate Director of Global Portfolio & Project Management at AstraZeneca, Rebecca leverages her management skills to aid in the development of biologics specifically in the Early Stage Respiratory & Immunology sector.

Adept at communication, Rebecca excels in relationship-building, stakeholder management, and presenting technical analyses to diverse audiences.

With a Ph.D. in Inorganic Chemistry (Bio emphasis) from the University of North Carolina at Chapel Hill, a B.S. in Chemistry from the University of Virginia, and specialized training in Drug and Medical Device Development from the Massachusetts Institute of Technology, Rebecca possesses a solid educational foundation.

Her professional journey includes roles such as Director of Biology, Assay Development at Akonni Biosystems, Senior Scientist at companies like CUBRC and Ionian Technologies (Acquired by Alere, Abbott), and a Post-doctoral Research Associate at The Scripps Research Institute.

Passionate about addressing health inequalities globally, Rebecca is dedicated to implementing life-saving technologies and strategies wherever they are required.

Highlights

Aug 9 · 360Dx
Akonni Biosystems Wins NIH SBIR Grant for Pediatric Respiratory Disease Diagnostics - 360Dx
Jun 27 · Artsy
15 New York Group Shows You Need to See This July - Artsy
R
Add to my network

Location

Gaithersburg, Maryland, United States